Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROLAPITANT vs ROMIDEPSIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROLAPITANT vs ROMIDEPSIN: Safety Overview

Metric ROLAPITANT ROMIDEPSIN
Total FAERS Reports 873 1,282
Deaths Reported 252 343
Death Rate 28.9% 26.8%
Hospitalizations 155 458
Average Patient Age 61.4 yrs 64.7 yrs
% Female Patients 57.5% 46.5%
FDA Approval Date Oct 25, 2017 Mar 13, 2020
Manufacturer TerSera Therapeutics LLC Fresenius Kabi USA, LLC
Route ORAL N/A
Marketing Status Prescription Prescription